Close mobile menu×
Close mobile menu

Anthony W. Ferrante Jr., MD, PhD

Board Certifications: 
Internal Medicine
Not Accepting New Patients
Profile Hero

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Internal Medicine

Education & Training

  • Albert Einstein College of Medicine - Yeshiva University
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • Fellow’s Prize of Saybrook College, Yale University
  • 1995 Alpha Omega Alpha, Albert Einstein College of Medicine
  • 1998 Affymetrix Academic User Award (Declined)
  • 1998-2000 Lucille P. Markey Charitable Trust Fellowship
  • 2001 Naomi Berrie Diabetes Research Award
  • 2006 Nature Medicine - Notable Advances in the Field of Metabolism (JCI 112; 1796-1808 [2003])
  • 2006 Gill Cardiovascular Center Visiting Professor – University of Kentucky
  • 2006 Gunnar Birke Lecture – Karolinska Institute
  • 2006 Dorothy and Daniel Silberberg Endowed Assistant Professorship in Medicine
  • 2009 John N. Loeb Lecture – Columbia University
  • 2009 UK Adipose Tissue Society Meeting – Keynote Lecture
  • 2010 Dean’s Emerging Concepts in Medicine Lecture - SUNY Downstate
  • 2010 Harold & Golden Lamport Award for Excellence in Clinical Research - Columbia University

About Anthony Ferrante

Anthony W. Ferrante Jr., MD, PhD is a physician scientist and the Dorothy and Daniel Silberberg Associate Professor of Medicine whose area of expertise includes obesity and metabolically related diseases. He runs a research laboratory devoted to understanding how changes in weight, and in particular fat, alter the function of other organs in our body, to defining the ways in which our body weight is regulated and to developing approaches to prevent the complications of obesity. He is board certified in Internal Medicine.

Dr. Ferrante obtained his BA in physics from Yale and received his MD and PhD from the Albert Einstein College of Medicine. He completed his clinical training in internal medicine at NewYork-Presbyterian Hospital/Columbia University Medical Center. He completed his research fellowship at the Naomi Berrie Diabetes Center of Columbia University.

Dr. Ferrante runs a research laboratory that has revealed that the immune system responds to changes in weight so that in the most obese individuals more than half of the cells that make up their fat are actually immune cells. His research efforts are now focused on understanding how the immune and metabolic systems interact and how the immune system can be used to be protect people from complications associated with obesity or even obesity itself.

Academic Titles

  • Associate Professor of Medicine

Committee/Societies/Council Memberships

  • Scientific Review Committee - American Diabetes Association
  • CSR - Intergrated Physiology of Obesity & Diabetes
  • CSR - NIDDK Collaborative Team Programs

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Contact & Locations

1
1150 St. Nicholas Avenue
New York, New York 10032
Phone:
(212) 851-5322
Primary

Research

For several decades it was known that obesity and related metabolic disorders increase the concentration inflammatory molecules found in the circulation and in key metabolic tissues. Studies in the Ferrante Laboratory revealed that the obesity-induced increases in inflammation are part of a complex immune response in which macrophages, T-cells and NK cells are recruited to metabolic organs and tissues during the development of \obesity, diabetes and non-alcoholic fatty liver disease. For example, in lean individuals macrophages constitute ~5% of the cells in adipose tissue, but in the most obese individuals 50% or more of the cells in a fat depot are macrophages. Studies from the Ferrante and other laboratories have demonstrated a close association of subpopulations of immune cells with the metabolic complications of obesity including diabetes and non-alcoholic fatty liver disease.

Much of the current work in the Ferrante Laboratory is focused on identifying and characterizing the immune cell populations that are altered by obesity and how the immune system regulates metabolism. By determining the adaptive and pathological functions of the immune system in metabolism, the laboratory identifies cells, pathways and molecules that are candidate targets for therapeutic interventions and that can be used to predict metabolic outcomes.

Research Interests

  • Work in the Ferrante Laboratory has revealed that the immune system recognizes and responds to changes in metabolic function. Studies in the laboratory focus on how the immune and metabolic systems interact.

Grants

ADIPOSE TISSUE MACROPHAGE PHENOTYPE AND FUNCTION (Federal Gov)

May 1 2017 - Apr 30 2022

ADIPOSE INFLAMMATION IN RHEUMATOID ARTHRITIS (Federal Gov)

Sep 15 2016 - Aug 31 2021

NEW YORK OBESITY RESEARCH CENTER (Federal Gov)

Dec 1 1996 - Mar 31 2021

DIABETES AND ENDOCRINOLOGY RESEARCH CENTER (Federal Gov)

Mar 15 2013 - Jan 31 2019

IMMUNE REGULATION OF ADIPOSE TISSUE MASS (Federal Gov)

Apr 14 2014 - Feb 28 2018

OBESITY, INFLAMMATION AND LUNG INJURY AFTER LUNG TRANSPLANTATION (Federal Gov)

May 23 2013 - Mar 31 2017

HEPATIC MYELOID CELLS REGULATED BY OBESITY (Federal Gov)

Aug 1 2009 - Jul 31 2014

NYORC ADIPOSE TISSUE CORE (Federal Gov)

Jun 10 2011 - Mar 31 2014

METABOLIC ADAPTATION AND CHANGES IN CENTRAL NERVOUS SYSTEM CIRCUITRY IN WEIGHT-PERTURBED C57BL/6J MICE (Private)

Jun 16 2008 - Nov 30 2013

CAREER TRACKS TOWARDS EXCELLENCE (Private)

Jul 1 1993 - Jun 30 2012

Selected Publications

  • Odegaard JI, *Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante Jr AW, Chawla A. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 :1116-1120
  • *Odegaard JI, *Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante Jr AW, Chawla A. (2008) PPAR-delta controls alternative (M2) activation of Kupffer cells to ameliorate insulin resistance Cell Metabolism 7:496-507
  • Martinez de Victoria E, Xu X, Koska J, Francisco AM, Scalise M, Ferrante AW, Jr., Krakoff J (2009) Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians Diabetes 58:385-393
  • Obstfeld AE, Sugaru E, Thearle MS, Francisco AM, Gayet C, Ginsberg HN, Ables EV, Ferrante Jr AW (2010) CCR2 regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis Diabetes 59:916-25
  • Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, Ferrante Jr AW. (2010) Weight Loss and lipolysis activate an immune response in mice Journal of Clinical Invesigation 120:3466-79